Elevated liver enzymes often pose a diagnostic dilemma for clinicians, due to their non-specific nature and wide array of potential etiologies. This article aims to provide a comprehensive approach to decipher this clinical conundrum.
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are the most commonly assessed liver enzymes. Their elevation is suggestive of hepatocellular injury. However, the degree of elevation does not necessarily correlate with the severity of liver damage.
Common causes include viral hepatitis, alcohol-related liver disease, non-alcoholic fatty liver disease, and drug-induced liver injury. Less common causes include autoimmune hepatitis, hemochromatosis, Wilson's disease, and alpha-1 antitrypsin deficiency.
A thorough history and physical examination should be the initial step. If the cause is not apparent, a systematic approach should be adopted. This includes ruling out common causes first, followed by screening for less common causes if initial investigations are inconclusive. Imaging studies and liver biopsy may be required in certain situations.
Management largely depends on the underlying cause. Lifestyle modifications and abstinence from alcohol are often recommended. Regular follow-up with liver function tests is essential to monitor response to treatment and progression of disease. In cases of persistent unexplained elevation, referral to a hepatologist may be necessary.
Elevated liver enzymes present a diagnostic challenge due to the broad differential diagnosis. A systematic and comprehensive approach can help clinicians in making an accurate diagnosis and initiating appropriate management. Continuous medical education and staying updated with the latest research are key to overcoming this diagnostic dilemma.
1.
Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.
2.
Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia
3.
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire
4.
Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy
5.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
1.
Ferroptosis as a Therapeutic Target in Cancer
2.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
3.
Adaptive Cell Therapies for Solid Tumors
4.
Engineered Niches for Blood-Cell Regeneration: Current Concepts and Clinical Implications
5.
Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation